Autolus Therapeutics Plc (AUTL)

$ 1.75
   
  • Change Today:
    $0.00
  • 52 Week High: $4.80
  • 52 Week Low: $1.29
  • Currency: US Dollars
  • Shares Issued: 7.81m
  • Volume: 1,348,627
  • Market Cap: $13.67m
  • RiskGrade: 363

Latest ShareCast News

Syncona's Autolus leukemia treatment meets trial endpoint

By Frank Prenesti

Date: Friday 09 Dec 2022

(Sharecast News) - Syncona portfolio company Autolus Therapeutics announced that a phase 2 clinical trial in adult acute lymphoblastic leukemia (ALL) patients has met its primary endpoint at interim analysis.

Autolus reports early progress with cancer drugs

By Oliver Haill

Date: Monday 03 Dec 2018

(Sharecast News) - Autolus Therapeutics reported progress in clinical trials for one of its cancer treatments and said it has begun dosing patients in another trial.

Autolus reports early progress with cancer drugs

By Oliver Haill

Date: Monday 03 Dec 2018

(Sharecast News) - Autolus Therapeutics reported progress in clinical trials for one of its cancer treatments and said it has begun dosing patients in another trial.

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AUTL Market Data

Currency US Dollars
Share Price $ 1.75
Change Today $ 0.00
% Change 0.00 %
52 Week High $4.80
52 Week Low $1.29
Volume 1,348,627
Shares Issued 7.81m
Market Cap $13.67m
RiskGrade 363

What The Brokers Say

Strong Buy 5
Buy 6
Neutral 0
Sell 0
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 22-Aug-2025

Time Volume / Share Price
16:00 62,438 @ $1.75
15:59 200 @ $1.76
15:59 200 @ $1.76
15:59 300 @ $1.76
15:59 200 @ $1.76

Top of Page